Restructuring events
European Restructuring Monitor (ERM)
The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
The German pharmaceutical company Ratiopharm, owned by the Israeli pharmaceutical company Teva, announced it will cut 300 jobs in Germany due to internal restructuring. The job losses will fall in Ratiopharm's sites in Ulm and Blaubeuren and the site in Berlin which will be shut down. The job reduction follows an announcement by Teva dating back to December 2017, announcing the loss of 14,000 jobs worldwide.
Negotiations between management and employee representatives will start shorty.
Previously in March 2017, Ratiopharm cut 100 jobs in Ulm.
Eurofound (2018), Ratiopharm, Internal restructuring in Germany, factsheet number 93162, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/93162.